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Two recent papers inGenes and Development argue that the ASPP1 protein has distinct roles in cell survival,
depending upon its subcellular localization, that are determined by a complex interplay with LATS kinase and
the YAP transcriptional cofactor.The ASPP family of proteins was originally
identified as playing an obligate role in
the transcriptional regulation of the tumor
suppressor p53 (see Sullivan and Lu,
2007). ASPP1 and ASPP2 were shown
to interact with p53 directly and selec-
tively enhance its transcriptional activity
on target genes that play a role in apo-
ptotic outcomes (Samuels-Lev et al.,
2001). The iASPP protein antagonizes
these effects and contributes to the
downregulation of a p53-mediate cell
death response (see Sullivan and Lu,
2007). These studies argued in favor of a
tumor suppressor role for ASPP1 and
ASPP2 in the nucleus. Two recent studies
in Genes and Development (Aylon et al.,
2010; Vigneron et al., 2010) now support
the notion that ASPP1 is predominantly
cytoplasmic in unstressed cells and that
this localization is determined by an inter-
play with LATS kinases and the YAP tran-
scriptional cofactor.
Both the LATS kinases (LATS1 and
LATS2) and YAP are components of the
Hippo signaling pathway in mammalian
cells (see Hergovich and Hemmings,
2009). Phosphorylation of YAP by the
LATS kinases leads to its cytoplasmic
localization and targeting for protein deg-
radation via the proteasome (see Bertini
et al., 2009). Vigneron et al. now demon-
strate that ASPP1 can antagonize the
interaction of YAP with the LATS kinases.
This prevents YAP phosphorylation on
serine 127 and results in its entry into the
nucleus, where it contributes to a tran-
scriptional program that enhances sur-
vival, notably including the downregula-
tion of the proapoptotic protein Bim
(Vigneron et al., 2010). That program
involves a role for YAP as a coactivator
of the transcription factor TEAD (Zhao
et al., 2008). Thus, localization of ASPP1to the cytoplasm enhances an oncogenic
activity of YAP.
In contrast, oncogenic signaling in
response to expression of activated Ras
stimulates the ability of the LATS kinases
to phosphorylate ASPP1 (Aylon et al.,
2010). Such modification of ASPP1 re-
sults in the translocation of the LATS-
ASPP1 complex to the nucleus, where it
selectively enhances the transcriptional
activity of the tumor suppressor p53 on
target genes that are specifically relevant
to apoptosis (Aylon et al., 2010). These
findings reinforce the idea that nuclear
ASPP1 plays a tumor-suppressing role.
Clearly, conventional notions of onco-
genes and tumor suppressors are chal-
lenged by the findings in these two
intriguing studies. The notion that subcel-
lular localization will inform whether a
specific protein promotes or inhibits pro-
liferation is exciting. This is especially true
when this occurs via distinct mechanisms
in each cellular compartment. Further,
this has important implications for how
a target suchasASPP1maybeusedeither
as a biomarker or a focus for therapeutic
intervention. As is often the case, these
exciting findings also raise additional,
compelling questions about the roles of
YAP and ASPP1 in oncogenesis.
While Vigneron et al. focus on the pro-
survival effects of localizing YAP to the
nucleus, they also note that YAP has
previously been shown to serve as a
cofactor for the p53 family member p73
(Figure 1) (Vigneron et al., 2010). Occu-
pying specific genes in conjunction with
p73, YAP has been shown to contribute
to transcriptional regulation that leads to
an apoptotic outcome (Strano et al.,
2005). Thus, the consequences for the
cell upon nuclear localization of YAP will
be determined to some extent by the rela-Cancer Cell 18, Ntive importance of its interplay with TEAD
(leading to survival) (Zhao et al., 2008) and
p73 (promoting cell death) (Strano et al.,
2005). Studies in human tumor samples
have indicated that YAP is often overex-
pressed in a subset of cancers (see Bertini
et al., 2009). This is more consistent
with an oncogenic role for YAP, yet its
interactions with p73 need to be more
fully understood. p73 is know to act in
response to specific agents that trigger
genotoxic DNA damage, whereas the
studies of Vigneron et al. did not directly
address the role of survival signaling of
YAP in this context.
Aylon et al. demonstrate a role for the
nuclear ASPP1/LATS complex in enhanc-
ing the transcriptional activity of p53
specifically on its target genes relevant
for apoptosis. Of interest, they note that
the outcome of this effect is selective
killing of polyploid cells (Aylon et al.,
2010). A previous study from the same
laboratory demonstrated that abrogation
of LATS2 expression promoted the pres-
ence of tetraploid cells (Aylon et al.,
2006). In their current study, they begin
to provide a mechanistic basis for this
earlier observation. Nevertheless, it is
unclear why polyploid cells would be
selectively targeted under these condi-
tions, given that the genes that are being
affected should be stimulating cell death
regardless of the actual DNA content.
It remains to be seen whether there is
a novel set of target genes that mediate
this effect or else that LATS2 may exert
other effects independent of the ASPP1-
p53 gene expression program.
In response to oncogenic signaling or
mitotic stress, LATS2 translocates from
the centrosome to the nucleus (Aylon
et al., 2006). The findings of Aylon
et al. indicate that ASPP1 accompaniesovember 16, 2010 ª2010 Elsevier Inc. 409
Figure 1. Mutually Exclusive Binding of ASPP1 or YAP to LATS
Kinases Determines Their Subcellular Localization and Respective
Roles in Regulating Gene Expression and Cell Survival
The YAP transcriptional cofactor and the ASPP1 protein bind to the LATS
kinases (LATS1 and LATS2) in a mutually exclusive manner (Aylon et al.,
2010; Vigneron et al., 2010). The binding of YAP to the LATS kinases leads to
its phosphorylation. This results in cytoplasmic sequestration of YAP and its
degradation via the proteasome (see Bertini et al., 2009). Cytoplasmic ASPP1
in unstressed cells interactswith the LATS kinases andprevents this YAPphos-
phorylation, leading to the nuclear accumulation of YAP (Vigneron et al., 2010).
Nuclear YAP has been shown to mediate distinct gene expression responses
(see Bertini et al., 2009). Interactions with the TEAD transcription factor
enhances cell survival (Zhao et al., 2008), whereas binding to the p53 family
member p73 promotes apoptosis (Strano et al., 2005). In cells transformed
by activated Ras, the LATS kinases phosphorylate ASPP1, resulting in the
translocation of thecomplex to the nucleuswhere it interactswith p53andstim-
ulates a gene expression profile that contributes to an apoptotic response (Ay-
lon et al., 2010; Samuels-Lev et al., 2001). High levels of YAP, as found in
subsets of human tumors, can, in turn, inhibit the interaction of LATS with
ASPP1 and prevent this nuclear accumulation of ASPP1 (Aylon et al., 2010).
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tions. Prior to such stimuli,
LATS2 is present in the cyto-
plasm, in complex with
ASPP1. Although the locali-
zation studies done thus far
do not indicate an association
of ASPP1 with the centro-
some, the intimate associa-
tion of ASPP1 and LATS2 in
unstressed cells detected by
coimmunoprecipitation sug-
gest that such a possibility
may exist. The precise role
of LATS as a centrosomal
protein and the potential
impact that ASPP1 may have
on such functions are also an
area worth exploring.
It should be noted that
these studies have not dis-
tinguished between the two
LATS kinases nor do they
address possible differences
between YAP and the closely
related TAZ protein. Mouse
knockout studies clearly show
distinct roles for ASPP1 and
ASPP2 (see Sullivan and
Lu, 2007). However, ASPP2
has also been implicated in
p53-dependent transcription
of target genes relevant
to apoptosis (Samuels-Lev
et al., 2001). The fact that
the gene encoding LATS2
itself is a transcriptional tar-
get for p53 creating a positive
feedback loop (Aylon et al.,
2006) raises the question of
whether p73 may have a
similar role. All these added
complexities need to beexplored and certainly have created
a cottage industry for this burgeoning
field.
It should be emphasized that the two
studies by Aylon et al. and Vigneron410 Cancer Cell 18, November 16, 2010 ª20et al. provide an important new paradigm
for understanding the functions of a
cancer gene product. The same pro-
tein, in this case ASPP1, can exert dis-
tinct and apparently opposing effects10 Elsevier Inc.depending upon its subcel-
lular localization. Most impor-
tantly, the relative levels of
each player in this complex
pathway—ASPP1, YAP, and
LATS—coordinately deter-
mine whether the outcome
is oncogenic or tumor sup-
pressing. Elucidating the key
determinants for this will
certainly provide fascinating
science and serve as a basis
for novel approaches to
understand and treat human
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